Cathepsins X and B display distinct activity profiles that can be exploited for inhibitor design
- PMID: 11517939
- DOI: 10.1515/BC.2001.102
Cathepsins X and B display distinct activity profiles that can be exploited for inhibitor design
Abstract
The carboxypeptidase and endopeptidase activities of cathepsins X and B, as well as their inhibition by E-64 derivatives, have been investigated in detail and compared. The results clearly demonstrate that cathepsins X and B do not share similar activity profiles against substrates and inhibitors. Using quenched fluorogenic substrates, we show that cathepsin X preferentially cleaves substrates through a monopeptidyl carboxypeptidase pathway, while cathepsin B displays a preference for the dipeptidyl pathway. The preference for one or the other pathway is about the same for both enzymes, i. e. approximately 2 orders of magnitude. Cleavage of a C-terminal dipeptide of a substrate by cathepsin X can be observed under conditions that preclude efficient monopeptidyl carboxypeptidase activity. In addition, an inhibitor designed to exploit the unique structural features responsible for the carboxypeptidase activity of cathepsin X has been synthesized and tested against cathepsins X, B and L. Although of moderate potency, this E-64 derivative is the first reported example of a cathepsin X-specific inhibitor. By comparison, CA074 was found to inactivate cathepsin B at least 34000-fold more efficiently than cathepsin X.
Similar articles
-
Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities.Biochemistry. 2001 Mar 6;40(9):2702-11. doi: 10.1021/bi002460a. Biochemistry. 2001. PMID: 11258881
-
The consequences of lysosomotropism on the design of selective cathepsin K inhibitors.Chembiochem. 2006 Oct;7(10):1525-35. doi: 10.1002/cbic.200600149. Chembiochem. 2006. PMID: 16921579 Review.
-
Development of peptidyl alpha-keto-beta-aldehydes as new inhibitors of cathepsin L--comparisons of potency and selectivity profiles with cathepsin B.Bioorg Med Chem Lett. 2000 Aug 7;10(15):1771-3. doi: 10.1016/s0960-894x(00)00340-1. Bioorg Med Chem Lett. 2000. PMID: 10937745
-
Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors.Exp Neurol. 1999 Feb;155(2):187-94. doi: 10.1006/exnr.1998.6988. Exp Neurol. 1999. PMID: 10072294
-
Development of cathepsin inhibitors and structure-based design of cathepsin B-specific inhibitor.Curr Top Med Chem. 2010;10(7):696-707. doi: 10.2174/156802610791113441. Curr Top Med Chem. 2010. PMID: 20337581 Review.
Cited by
-
Identification and characterization of the novel reversible and selective cathepsin X inhibitors.Sci Rep. 2017 Sep 13;7(1):11459. doi: 10.1038/s41598-017-11935-1. Sci Rep. 2017. PMID: 28904354 Free PMC article.
-
Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2497-502. doi: 10.1073/pnas.0907240107. Epub 2010 Jan 21. Proc Natl Acad Sci U S A. 2010. PMID: 20133781 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources